David R. Maslov
David R. Maslov has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alexander S. Kusai
Kirov Military Medical Academy
3 shared publications - Ildar R. Mukhamedzhanov
Kirov Military Medical Academy
3 shared publications - Maxim V. Ganzha
Main Military Clinical Hospital named after Academician N.N. Burdenko
3 shared publications - Roman E. Lakhin
Kirov Military Medical Academy; Saratov State Medical University named after V.I. Razumovsky
3 shared publications - Rustam R. Kasimov
Kirov Military Medical Academy; 442nd District Military Clinical Hospital named after Z.P. Solovyov
3 shared publications - Aleksei Valerianovich Shchegolev
Kirov Military Medical Academy
2 shared publications
Latest Publications
- 16 November 2026
- Published by ECO-Vector LLC (Publications) in Bulletin of the Russian Military Medical Academy
- Vol. 28 (4) , 509-518
Comparative efficacy of two doses of hyperbaric bupivacaine (10 and 12.5 mg) for unilateral spinal anesthesia in patients with lower limb wounds and uncompensated blood loss
BACKGROUND: Unilateral spinal anesthesia minimizes hemodynamic compromise in patients with blood loss, but the optimal dose of hyperbaric bupivacaine in this population remains undefined. AIM: To compare the efficacy of two doses (10 and 12.5 mg) of 0.5% hyperbaric bupivacaine in unilateral spinal anesthesia in patients with injuries and wounds of the lower limbs and uncompensated blood loss. METHODS: A total of 61 patients (all men) with injuries, wounds of the lower limbs, and signs of uncompensated blood loss were examined (shock index: 0.89 [0.81; 1.23] conventional units; hemoglobin: 9.37 [7.65; 12.3] g/dL). They underwent surgery under unilateral spinal anesthesia and were divided into two groups. Group 1 included 21 patients who received 10 mg of 0.5% hyperbaric bupivacaine during unilateral spinal anesthesia. Group 2 included 40 patients who received 12.5 mg of 0.5% hyperbaric bupivacaine during unilateral spinal anesthesia. For all patients, the dynamics of sensory (5-point scale) and motor blockade (modified Bromage scale), the frequency of vasopressor support, the need for additional analgesia, and adverse events were assessed. RESULTS: An adequate unilateral block was achieved in 100% of patients. In group 2, compared with group 1, sensory and motor blockade developed faster in the first 10 minutes (p 0.05); however, after the 15th minute, partial spread of the block to the contralateral side was observed (the difference Δ between the limbs decreased from 2.3 to 1.5 points, p 0.001). The frequency of vasopressor support was 16.4% (11.5%—phenylephrine, 4.9%—norepinephrine); additional analgesia was required in 4 (6.6%) patients in group 1. No adverse events related to anesthesia were recorded. The need for vasopressors correlated with the delay in blood loss replacement, not with the fact of performing unilateral spinal anesthesia. CONCLUSION: Both doses of 0.5% hyperbaric bupivacaine provide adequate anesthesia. The 12.5 mg dose allows for faster blockade but is associated with partial spread to the contralateral side. The 10 mg dose is preferable when maximum unilateral blockade is required. If the selection criteria are met and timely infusion therapy is provided, unilateral spinal anesthesia is safe in patients with uncompensated moderate blood loss. The need for vasopressors is associated with delayed blood loss replacement.
- 16 November 2026
- Published by ECO-Vector LLC (Publications) in Bulletin of the Russian Military Medical Academy
- Vol. 28 (4) , 509-518
Comparative efficacy of two doses of hyperbaric bupivacaine (10 and 12.5 mg) for unilateral spinal anesthesia in patients with lower limb wounds and uncompensated blood loss
BACKGROUND: Unilateral spinal anesthesia minimizes hemodynamic compromise in patients with blood loss, but the optimal dose of hyperbaric bupivacaine in this population remains undefined. AIM: To compare the efficacy of two doses (10 and 12.5 mg) of 0.5% hyperbaric bupivacaine in unilateral spinal anesthesia in patients with injuries and wounds of the lower limbs and uncompensated blood loss. METHODS: A total of 61 patients (all men) with injuries, wounds of the lower limbs, and signs of uncompensated blood loss were examined (shock index: 0.89 [0.81; 1.23] conventional units; hemoglobin: 9.37 [7.65; 12.3] g/dL). They underwent surgery under unilateral spinal anesthesia and were divided into two groups. Group 1 included 21 patients who received 10 mg of 0.5% hyperbaric bupivacaine during unilateral spinal anesthesia. Group 2 included 40 patients who received 12.5 mg of 0.5% hyperbaric bupivacaine during unilateral spinal anesthesia. For all patients, the dynamics of sensory (5-point scale) and motor blockade (modified Bromage scale), the frequency of vasopressor support, the need for additional analgesia, and adverse events were assessed. RESULTS: An adequate unilateral block was achieved in 100% of patients. In group 2, compared with group 1, sensory and motor blockade developed faster in the first 10 minutes (p 0.05); however, after the 15th minute, partial spread of the block to the contralateral side was observed (the difference Δ between the limbs decreased from 2.3 to 1.5 points, p 0.001). The frequency of vasopressor support was 16.4% (11.5%—phenylephrine, 4.9%—norepinephrine); additional analgesia was required in 4 (6.6%) patients in group 1. No adverse events related to anesthesia were recorded. The need for vasopressors correlated with the delay in blood loss replacement, not with the fact of performing unilateral spinal anesthesia. CONCLUSION: Both doses of 0.5% hyperbaric bupivacaine provide adequate anesthesia. The 12.5 mg dose allows for faster blockade but is associated with partial spread to the contralateral side. The 10 mg dose is preferable when maximum unilateral blockade is required. If the selection criteria are met and timely infusion therapy is provided, unilateral spinal anesthesia is safe in patients with uncompensated moderate blood loss. The need for vasopressors is associated with delayed blood loss replacement.
- Open Access
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 173-185
Effect of infusion of 0.9 % sodium chloride solution and meglumine sodium succinate on acid‑base status in trauma patients: a randomized comparative study
INTRODUCTION: Blood loss in severe trauma leads to shock, microcirculatory disorders, and disturbances of acid-base status (ABS). Initial resuscitation uses crystalloids that affect ABS. OBJECTIVE: To compare the effects of 0.9 % saline vs. meglumine sodium succinate (Reamberin®) on ABS and electrolyte balance in patients with severe trauma. MATERIALS AND METHODS: Prospective randomized trial of 30 patients (15 per group). Group 1 received 1000 mL 0.9 % NaCl, Group 2 — 1000 mL meglumine sodium succinate. ABS, electrolytes, anion gap (AG), and strong ion difference (SID) were measured before and after infusion. RESULTS: After infusion, the meglumine sodium succinate group showed significantly better ABS: pH 7.386 (7.294; 7.498) vs 7.242 (7.203; 7.336); p = 0.013; HCO3− 24.50 (20.31; 27.90) vs 19.80 (15.37; 22.30) mmol/L; p = 0.018; BE 1.10 (−5.81; 2.52) vs −6.60 (−12.68; −3.08) mmol/L; p = 0.007. In the 0.9 % NaCl group, chloride increased from 105.2 to 110.4 mmol/L (p = 0.03) and AG increased (p = 0.01). CONCLUSIONS: Infusion of meglumine sodium succinate in patients with severe trauma and uncompensated blood loss provides effective correction of metabolic acidosis, as confirmed by normalization of pH, HCO3-act, BE, as well as favorable dynamics of anion gap and stable strong ion difference. The use of 0.9 % sodium chloride solution is associated with worsening acidosis and development of hyperchloremic disorders, as evidenced by increased chloride levels, decreased strong ion difference, and elevated anion gap.
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 173-185
Open AccessEffect of infusion of 0.9 % sodium chloride solution and meglumine sodium succinate on acid‑base status in trauma patients: a randomized comparative study
INTRODUCTION: Blood loss in severe trauma leads to shock, microcirculatory disorders, and disturbances of acid-base status (ABS). Initial resuscitation uses crystalloids that affect ABS. OBJECTIVE: To compare the effects of 0.9 % saline vs. meglumine sodium succinate (Reamberin®) on ABS and electrolyte balance in patients with severe trauma. MATERIALS AND METHODS: Prospective randomized trial of 30 patients (15 per group). Group 1 received 1000 mL 0.9 % NaCl, Group 2 — 1000 mL meglumine sodium succinate. ABS, electrolytes, anion gap (AG), and strong ion difference (SID) were measured before and after infusion. RESULTS: After infusion, the meglumine sodium succinate group showed significantly better ABS: pH 7.386 (7.294; 7.498) vs 7.242 (7.203; 7.336); p = 0.013; HCO3− 24.50 (20.31; 27.90) vs 19.80 (15.37; 22.30) mmol/L; p = 0.018; BE 1.10 (−5.81; 2.52) vs −6.60 (−12.68; −3.08) mmol/L; p = 0.007. In the 0.9 % NaCl group, chloride increased from 105.2 to 110.4 mmol/L (p = 0.03) and AG increased (p = 0.01). CONCLUSIONS: Infusion of meglumine sodium succinate in patients with severe trauma and uncompensated blood loss provides effective correction of metabolic acidosis, as confirmed by normalization of pH, HCO3-act, BE, as well as favorable dynamics of anion gap and stable strong ion difference. The use of 0.9 % sodium chloride solution is associated with worsening acidosis and development of hyperchloremic disorders, as evidenced by increased chloride levels, decreased strong ion difference, and elevated anion gap.
- Open Access
- 4 June 2026
- Published by ECO-Vector LLC (Publications) in Regional Anesthesia and Acute Pain Management
- Vol. 20 (2) , 159-165
Proximal costoclavicular block for upper extremity trauma and injury surgery in patients with uncompensated blood loss: a case series
Introduction: The proximal costoclavicular approach to the brachial plexus is considered an anatomically advantageous alternative to the classical infraclavicular approach due to the compact arrangement of all three cords within a single fascial sheath. This potentially provides a faster and more predictable onset of the block and reduces the risk of complications. However, data from comparative studies on the speed of sensory and motor block onset remain contradictory, and clinical experience with this technique in routine practice requires further accumulation. Case description: This article presents a case series of 32 patients (median age 38 years) who underwent upper limb surgery (elbow region—8 cases, forearm—16 cases, hand—8 cases). All patients received a brachial plexus block using the proximal costoclavicular approach under ultrasound guidance (LOGIQ system, 12L-RS probe). A mixture of local anesthetics was used: 10 mL of 0.75% ropivacaine and 6 mL of 2% lidocaine (total volume 16 mL). The efficacy of the block was assessed every 5 minutes for 30 minutes post-injection using a 3-point scale. Successful sensory block was achieved in 31 patients (96.9%). The median time to achieve complete sensory anesthesia was 10 minutes [Q1; Q3: 8; 13], and complete motor palsy was 15 minutes [12; 18]. In 5 patients (15.6%), visualization of the cords was suboptimal; however, the block was successful in 4 of them (80%). No complications such as Horner’s syndrome, dysphonia, pneumothorax, or diaphragm paresis were recorded. Conclusion: This case series demonstrates that ultrasound-guided costoclavicular block is a highly effective (96.9%) and safe method of regional anesthesia. The technique provides a predictable block onset time (10–15 minutes) and can be successfully performed even under conditions of suboptimal anatomical visualization. These findings are consistent with the results of recent systematic reviews and confirm the clinical value of the costoclavicular approach in anesthesiology practice.
- 4 June 2026
- Published by ECO-Vector LLC (Publications) in Regional Anesthesia and Acute Pain Management
- Vol. 20 (2) , 159-165
Open AccessProximal costoclavicular block for upper extremity trauma and injury surgery in patients with uncompensated blood loss: a case series
Introduction: The proximal costoclavicular approach to the brachial plexus is considered an anatomically advantageous alternative to the classical infraclavicular approach due to the compact arrangement of all three cords within a single fascial sheath. This potentially provides a faster and more predictable onset of the block and reduces the risk of complications. However, data from comparative studies on the speed of sensory and motor block onset remain contradictory, and clinical experience with this technique in routine practice requires further accumulation. Case description: This article presents a case series of 32 patients (median age 38 years) who underwent upper limb surgery (elbow region—8 cases, forearm—16 cases, hand—8 cases). All patients received a brachial plexus block using the proximal costoclavicular approach under ultrasound guidance (LOGIQ system, 12L-RS probe). A mixture of local anesthetics was used: 10 mL of 0.75% ropivacaine and 6 mL of 2% lidocaine (total volume 16 mL). The efficacy of the block was assessed every 5 minutes for 30 minutes post-injection using a 3-point scale. Successful sensory block was achieved in 31 patients (96.9%). The median time to achieve complete sensory anesthesia was 10 minutes [Q1; Q3: 8; 13], and complete motor palsy was 15 minutes [12; 18]. In 5 patients (15.6%), visualization of the cords was suboptimal; however, the block was successful in 4 of them (80%). No complications such as Horner’s syndrome, dysphonia, pneumothorax, or diaphragm paresis were recorded. Conclusion: This case series demonstrates that ultrasound-guided costoclavicular block is a highly effective (96.9%) and safe method of regional anesthesia. The technique provides a predictable block onset time (10–15 minutes) and can be successfully performed even under conditions of suboptimal anatomical visualization. These findings are consistent with the results of recent systematic reviews and confirm the clinical value of the costoclavicular approach in anesthesiology practice.